Skye Bioscience Inc (SKYE)

[zenvesting]

Emerald Health Sciences bought a little over 58% of NMUS, not their public subsidiary company Emerald Health Theraputics (EMH.v) who received the financing. Observe the corporate structure under the "Investments" tab on Emerald Health Sciences page:
http://emerald.life/pharmaceutical/

You'll notice EMH.v is discussed under "Botanicals".

If you look at slide 4 from the NMUS presentation the first bullet point says:
- Emerald Health Sciences is an operating company focused on the medical potential of cannabis and cannabanoids. Is mission is to identify and invest in operating subsidiaries that offer it unique opportunities and provide appropriate resources to advance the development of subsidiaries and their technologies.

Going back to the Emerald Health Sciences website, you'll see that the Pharmaceutical tab just mentions their two New Chemical Entities (NCEs) and no specific mention of an operating company.

There is definitely grounds to speculate that NMUS could serve as a reverse merger candidate to bring "Emerald Health Pharmaceuticals" public, similar to how they brought Emerald Health Botanicals (Medna Biosciences at the time) came public through an RM with T-Bird Pharma:
https://www.investinmj.com/directory/growers/t-bird-pharma

There is certainly more questions than answers at this point, but I have bought my starter position and anxiously await the updates they said may be forthcoming on "restructuring".....could involve a reverse split as well and scare some traders away.....I'll be waiting with a keen eye to see how us minority shareholders will be treated in these potential upcoming transactions.